| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 135.85B | 135.88B | 132.97B | 123.34B | 113.67B | 133.74B |
| Gross Profit | 27.79B | 27.56B | 28.25B | 23.58B | 23.01B | 22.73B |
| EBITDA | 13.62B | 13.72B | 13.00B | 9.54B | 9.76B | 9.85B |
| Net Income | 8.11B | 8.09B | 7.34B | 10.03B | 5.13B | 4.93B |
Balance Sheet | ||||||
| Total Assets | 134.46B | 137.61B | 141.67B | 133.99B | 120.28B | 114.96B |
| Cash, Cash Equivalents and Short-Term Investments | 20.01B | 21.12B | 26.65B | 32.20B | 26.17B | 23.88B |
| Total Debt | 117.00M | 216.00M | 277.00M | 354.00M | 562.00M | 727.00M |
| Total Liabilities | 47.69B | 50.93B | 56.98B | 52.51B | 47.38B | 46.17B |
| Stockholders Equity | 86.39B | 86.25B | 79.67B | 76.97B | 68.67B | 64.78B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 218.00M | 2.05B | 3.21B | 3.11B | 3.54B |
| Operating Cash Flow | 0.00 | 7.17B | 8.14B | 4.61B | 6.20B | 6.76B |
| Investing Cash Flow | 0.00 | -7.31B | -5.22B | 3.55B | -2.67B | -2.69B |
| Financing Cash Flow | 0.00 | -5.62B | -8.60B | -2.48B | -1.82B | -3.03B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | ¥81.33B | 19.80 | ― | 1.12% | 3.77% | 7.65% | |
77 Outperform | ¥108.37B | 10.07 | ― | 3.72% | 5.40% | 14.80% | |
76 Outperform | ¥79.74B | 6.04 | ― | 3.04% | 1.57% | -33.97% | |
76 Outperform | ¥86.91B | 7.61 | ― | 3.02% | 1.66% | 11.28% | |
75 Outperform | ¥575.11B | 20.62 | ― | 3.26% | 11.78% | 8.98% | |
62 Neutral | ¥24.72B | 9.97 | ― | 4.27% | 5.72% | 28.92% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% |